Derek T. Chalmers - Aug 30, 2021 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
President & CEO, Director
Signature
/s/Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Aug 30, 2021
Transactions value $
-$119,848
Form type
4
Date filed
9/1/2021, 06:04 PM
Previous filing
Aug 26, 2021
Next filing
Sep 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$120K -8.44K -0.83% $14.20 1.01M Aug 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs reported in the Form 4 filed with the Securities and Exchange Commission on August 26, 2021, and does not represent a discretionary trade by the Reporting Person.